Clinical Trial Update: Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing liraglutide versus bariatric surgery for weight loss and metabolic endpoints in obese Asian adults with NAFLD/NASH, focusing on liver …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis
• Weight Loss Disorders

Drugs mentioned

• Bariatric Surgery
• liraglutide (liraglutide)

Snippet

Sponsor: Changi General Hospital | Conditions: Non-alcoholic Fatty Liver Disease (NAFLD), Weight Loss | Phase 3 | Status: UNKNOWN